VALUE HEALTH ADDS $241 MIL IN NEW ACCOUNTS FOR 1994; VALUERx SUBSIDIARY IS NO LONGER FOR SALE; BERGEN BRUNSWIG FY 1994 SALES CLIMB 10% TO $7.5 BIL.
Executive Summary
Value Health's specialty managed care benefit programs have added new customer accounts in 1994 representing $242 mil. in annual revenues, the company reported Nov. 3. For 1995, the company has "booked $137 mil. in new annualized revenues, which is 40% ahead of last year's growth at this time," Value Health said.
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth